High-dose topical bevacizumab for corneal neovascularization.
Waisbourd M, Levinger E, Varssano D, Moisseiev E, Zayit-Soudri S, Barak A, Loewenstein A, Barequet I.
Waisbourd M, et al. Among authors: loewenstein a.
Pharmacology. 2013;92(5-6):310-4. doi: 10.1159/000356407. Epub 2013 Dec 4.
Pharmacology. 2013.
PMID: 24335191
Clinical Trial.